{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:36:01Z","timestamp":1794436561274,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut national de recherche en informatique et en automatique"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While there seems to be a consensus that a decrease in gut microbiome diversity is related to a decline in health status, the associations between respiratory microbiome diversity and chronic lung disease remain a matter of debate. We provide a systematic review and meta-analysis of studies examining lung microbiota alpha-diversity in patients with asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) or bronchiectasis (NCFB), in which a control group based on disease status or healthy subjects is provided for comparison.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We reviewed 351 articles on title and abstract, of which 27 met our inclusion criteria for systematic review. Data from 24 of these studies were used in the meta-analysis. We observed a trend that CF patients have a less diverse respiratory microbiota than healthy individuals. However, substantial heterogeneity was present and detailed using random-effects models, which limits the comparison between studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Knowledge on respiratory microbiota is under construction, and for the moment, it seems that alpha-diversity measurements are not enough documented to fully understand the link between microbiota and health, excepted in CF context which represents the most studied chronic respiratory disease with consistent published data to link alpha-diversity and lung function. Whether differences in respiratory microbiota profiles have an impact on chronic respiratory disease symptoms and\/or evolution deserves further exploration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02132-4","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T11:02:54Z","timestamp":1661252574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Marta","family":"Avalos-Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Alin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"M\u00e9tayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Thi\u00e9baut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Enaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Delhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"issue":"6","key":"2132_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard M, Beaugerie L. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039\u201348.","journal-title":"Gut."},{"issue":"6","key":"2132_CR2","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut J, Kan Q, Li L, Zheng S. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68(6):1014\u201323.","journal-title":"Gut."},{"issue":"6","key":"2132_CR3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174\u201382.","journal-title":"Gut."},{"issue":"12","key":"2132_CR4","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4014\/jmb.1709.09027","volume":"27","author":"B-R Kim","year":"2017","unstructured":"Kim B-R, Shin J, Guevarra RB, Lee JH, Kim DW, Seol K-H, Lee J-H, Kim HB, Isaacson RE. Deciphering diversity indices for a better understanding of microbial communities. J Microbiol Biotechnol. 2017;27(12):2089\u201393.","journal-title":"J Microbiol Biotechnol"},{"issue":"11","key":"2132_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1164\/rccm.201312-2129PP","volume":"189","author":"K Whiteson","year":"2014","unstructured":"Whiteson K, Bailey B, Bergkessel M, Conrad D, Delhaes L, Felts B, Harris J, Hunter R, Lim Y, Maughan H, Quinn R, Salamon P, Sullivan J, Wagner B, Rainey P. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med. 2014;189(11):1309\u201315.","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"2132_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"W Man","year":"2017","unstructured":"Man W, de Steenhuijsen Piters W, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15(5):259\u201370.","journal-title":"Nat Rev Microbiol."},{"issue":"6","key":"2132_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","volume":"8","author":"JB Soriano","year":"2020","unstructured":"Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, Adhikari TB, Advani SM, Agrawal A, Ahmadian E. Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585\u201396.","journal-title":"Lancet Respir Med"},{"issue":"15","key":"2132_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150473","volume":"131","author":"S Whiteside","year":"2021","unstructured":"Whiteside S, McGinniss J, Collman R. The lung microbiome: progress and promise. J Clin Invest. 2021;131(15): 150473.","journal-title":"J Clin Invest."},{"key":"2132_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrmicro.2017.122","volume":"16","author":"W Cookson","year":"2018","unstructured":"Cookson W, Cox M, Moffatt M. New opportunities for managing acute and chronic lung infections. Nat Rev Microbiol. 2018;16:111\u201320.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"2132_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP. The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"7","key":"2132_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.7326\/L15-5144-2","volume":"163","author":"B Hutton","year":"2015","unstructured":"Hutton B, Moher D, Cameron C. The prisma extension statement. Ann Intern Med. 2015;163(7):566\u20137.","journal-title":"Ann Intern Med"},{"issue":"15","key":"2132_CR12","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"9","key":"2132_CR13","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1177\/0962280219889080","volume":"29","author":"S McGrath","year":"2021","unstructured":"McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A, Collaboration DSDD. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2021;29(9):2520\u201337.","journal-title":"Stat Methods Med Res"},{"key":"2132_CR14","unstructured":"Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from https:\/\/www.training.cochrane.org\/handbook."},{"issue":"3","key":"2132_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"issue":"7414","key":"2132_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"2","key":"2132_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/gepi.20048","volume":"28","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2):123\u201337.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"2132_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11634-014-0195-1","volume":"10","author":"V Audigier","year":"2016","unstructured":"Audigier V, Husson F, Josse J. A principal component method to impute missing values for mixed data. Adv Data Anal Classif. 2016;10(1):5\u201326.","journal-title":"Adv Data Anal Classif"},{"issue":"1","key":"2132_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/biom.12974","volume":"75","author":"R De Vito","year":"2019","unstructured":"De Vito R, Bellio R, Trippa L, Parmigiani G. Multi-study factor analysis. Biometrics. 2019;75(1):337\u201346.","journal-title":"Biometrics"},{"issue":"4","key":"2132_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/all.13608","volume":"74","author":"J-J Lee","year":"2018","unstructured":"Lee J-J, Kim S-H, Lee M-J, Kim B-K, Song W-J, Park H-W, Cho S-H, Hong S-J, Chang Y-S, Kim B-S. Different upper airway microbiome and their functional genes associated with asthma in young adults and elderly individuals. Allergy. 2018;74(4):709\u201319.","journal-title":"Allergy"},{"key":"2132_CR21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3389\/fmicb.2020.01758","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu H, Wang F, Yang Y, Wang X, Chen B, Stampfli MR, Zhou H, Shu W, Brightling CE. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758.","journal-title":"Front Microbiol"},{"issue":"1","key":"2132_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00810-3","volume":"8","author":"L Cuthbertson","year":"2020","unstructured":"Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, Ashare A, Elborn JS, De Soyza A, Carroll MP. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020;8(1):1\u201313.","journal-title":"Microbiome"},{"issue":"10","key":"2132_CR23","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1371\/journal.pone.0007370","volume":"4","author":"D Willner","year":"2009","unstructured":"Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PloS One. 2009;4(10):7370.","journal-title":"PloS One"},{"issue":"3","key":"2132_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4046\/trd.2016.79.3.165","volume":"79","author":"J-W Jung","year":"2016","unstructured":"Jung J-W, Choi J-C, Shin J-W, Kim J-Y, Park I-W, Choi BW, Park H-W, Cho S-H, Kim K, Kang H-R. Lung microbiome analysis in steroid-naive asthma patients by using whole sputum. Tuberc Respir Dis. 2016;79(3):165.","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"2132_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-017-0234-1","volume":"5","author":"R Feigelman","year":"2017","unstructured":"Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, Brutsche MH, von Mering C. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome. 2017;5(1):1\u201314.","journal-title":"Microbiome"},{"issue":"17","key":"2132_CR26","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1128\/JB.00566-12","volume":"194","author":"L Filkins","year":"2012","unstructured":"Filkins L, Hampton T, Gifford A, Gross M, Hogan D, Sogin M, Morrison H, Paster B, O\u2019Toole G. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol. 2012;194(17):4709\u201317.","journal-title":"J Bacteriol"},{"issue":"3","key":"2132_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","volume":"10","author":"LA Carmody","year":"2013","unstructured":"Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, Li JZ, LiPuma JJ. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc. 2013;10(3):179\u201387.","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"2132_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1164\/rccm.201304-0775OC","volume":"188","author":"E Goleva","year":"2013","unstructured":"Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, Good JT Jr, Gelfand EW, Martin RJ, Leung DY. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013;188(10):1193\u2013201.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2132_CR29","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jaci.2015.10.017","volume":"137","author":"DR Denner","year":"2016","unstructured":"Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol. 2016;137(5):1398\u2013405.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2132_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jaci.2016.10.046","volume":"140","author":"A Sverrild","year":"2017","unstructured":"Sverrild A, Kiilerich P, Brejnrod A, Pedersen R, Porsbjerg C, Bergqvist A, Erjef\u00e4lt JS, Kristiansen K, Backer V. Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome. J Allergy Clin Immunol. 2017;140(2):407\u201317.","journal-title":"J Allergy Clin Immunol"},{"key":"2132_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3389\/fmicb.2020.01647","volume":"11","author":"H-Y Liu","year":"2020","unstructured":"Liu H-Y, Li C-X, Liang Z-Y, Zhang S-Y, Yang W-Y, Ye Y-M, Lin Y-X, Chen R-C, Zhou H-W, Su J. The interactions of airway bacterial and fungal communities in clinically stable asthma. Front Microbiol. 2020;11:1647.","journal-title":"Front Microbiol"},{"key":"2132_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.rmed.2017.08.016","volume":"131","author":"N Li","year":"2017","unstructured":"Li N, Qiu R, Yang Z, Li J, Chung KF, Zhong N, Zhang Q. Sputum microbiota in severe asthma patients: relationship to eosinophilic inflammation. Respir Med. 2017;131:192\u20138.","journal-title":"Respir Med"},{"issue":"2","key":"2132_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jaci.2012.11.013","volume":"131","author":"PR Marri","year":"2013","unstructured":"Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346\u201352.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2132_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13601-020-00345-8","volume":"10","author":"C Huang","year":"2020","unstructured":"Huang C, Yu Y, Du W, Liu Y, Dai R, Tang W, Wang P, Zhang C, Shi G. Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma. Clin Transl Allergy. 2020;10(1):1\u201313.","journal-title":"Clin Transl Allergy"},{"issue":"7","key":"2132_CR35","doi-asserted-by":"publisher","first-page":"0158622","DOI":"10.1371\/journal.pone.0158622","volume":"11","author":"C Munck","year":"2016","unstructured":"Munck C, Helby J, Westergaard CG, Porsbjerg C, Backer V, Hansen LH. Smoking cessation and the microbiome in induced sputum samples from cigarette smoking asthma patients. PloS One. 2016;11(7):0158622.","journal-title":"PloS One"},{"issue":"10","key":"2132_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109710","volume":"9","author":"H Park","year":"2014","unstructured":"Park H, Shin JW, Park S-G, Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PloS One. 2014;9(10): 109710.","journal-title":"PloS One"},{"issue":"2","key":"2132_CR37","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.1371\/journal.pone.0016384","volume":"6","author":"JR Erb-Downward","year":"2011","unstructured":"Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B. Analysis of the lung microbiome in the \u201chealthy\u2019\u2019 smoker and in COPD. PloS One. 2011;6(2):16384.","journal-title":"PloS One"},{"issue":"10","key":"2132_CR38","doi-asserted-by":"publisher","first-page":"47305","DOI":"10.1371\/journal.pone.0047305","volume":"7","author":"AA Pragman","year":"2012","unstructured":"Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PloS One. 2012;7(10):47305.","journal-title":"PloS One"},{"issue":"9","key":"2132_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/thoraxjnl-2015-207235","volume":"71","author":"G Einarsson","year":"2016","unstructured":"Einarsson G, Comer D, McIlreavey L, Parkhill J, Ennis M, Tunney M, Elborn J. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71(9):795\u2013803.","journal-title":"Thorax"},{"issue":"4","key":"2132_CR40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/emm.2017.7","volume":"49","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Kim Y-S, Kim K-H, Choi J-P, Kim Y-K, Yun S, Sharma L, Cruz CSD, Lee JS, Oh Y-M. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. Exp Mol Med. 2017;49(4):316\u2013316.","journal-title":"Exp Mol Med"},{"issue":"12","key":"2132_CR41","doi-asserted-by":"publisher","first-page":"0144448","DOI":"10.1371\/journal.pone.0144448","volume":"10","author":"L Millares","year":"2015","unstructured":"Millares L, P\u00e9rez-Brocal V, Ferrari R, Gallego M, Pomares X, Garcia-Nunez M, Monton C, Capilla S, Monso E, Moya A. Functional metagenomics of the bronchial microbiome in COPD. PloS One. 2015;10(12):0144448.","journal-title":"PloS One"},{"issue":"3","key":"2132_CR42","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/lary.27454","volume":"129","author":"SD Pletcher","year":"2019","unstructured":"Pletcher SD, Goldberg AN, Cope EK. Loss of microbial niche specificity between the upper and lower airways in patients with cystic fibrosis. Laryngoscope. 2019;129(3):544\u201350.","journal-title":"Laryngoscope"},{"issue":"1","key":"2132_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60015-4","volume":"10","author":"P Soret","year":"2020","unstructured":"Soret P, Vandenborght L-E, Francis F, Coron N, Enaud R, Avalos M, Schaeverbeke T, Berger P, Fayon M, Thiebaut R. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis. Sci Rep. 2020;10(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"1","key":"2132_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-017-0289-z","volume":"5","author":"V Narayanamurthy","year":"2017","unstructured":"Narayanamurthy V, Sweetnam JM, Denner DR, Chen LW, Naureckas ET, Laxman B, White SR. The metabolic footprint of the airway bacterial community in cystic fibrosis. Microbiome. 2017;5(1):1\u201311.","journal-title":"Microbiome"},{"issue":"1","key":"2132_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep10241","volume":"5","author":"B Coburn","year":"2015","unstructured":"Coburn B, Wang PW, Caballero JD, Clark ST, Brahma V, Donaldson S, Zhang Y, Surendra A, Gong Y, Tullis DE. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015;5(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"8","key":"2132_CR46","doi-asserted-by":"publisher","first-page":"0183553","DOI":"10.1371\/journal.pone.0183553","volume":"12","author":"MK Byun","year":"2017","unstructured":"Byun MK, Chang J, Kim HJ, Jeong SH. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis. PLoS One. 2017;12(8):0183553.","journal-title":"PLoS One"},{"key":"2132_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1513\/AnnalsATS.201506-319AW","volume":"2","author":"Y Huang","year":"2015","unstructured":"Huang Y, Boushey H. The sputum microbiome in chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc Suppl. 2015;2:176\u201380.","journal-title":"Ann Am Thorac Soc Suppl"},{"issue":"9","key":"2132_CR48","doi-asserted-by":"publisher","first-page":"0222449","DOI":"10.1371\/journal.pone.0222449","volume":"14","author":"S Tangedal","year":"2019","unstructured":"Tangedal S, Nielsen R, Aanerud M, Persson L, Wiker H, Bakke P, Hiemstra P, Eagan T. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLoS One. 2019;14(9):0222449.","journal-title":"PLoS One"},{"issue":"4","key":"2132_CR49","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jaci.2020.08.035","volume":"147","author":"LE Vandenborght","year":"2021","unstructured":"Vandenborght LE, Enaud R, Urien C, Coron N, Girodet PO, Ferreira S, Berger P, Delhaes L. Type 2-high asthma is associated with a specific indoor mycobiome and microbiome. J Allergy Clin Immunol. 2021;147(4):1296\u2013305.","journal-title":"J Allergy Clin Immunol"},{"key":"2132_CR50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fphys.2018.01168","volume":"9","author":"E Mathieu","year":"2018","unstructured":"Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, Remot A, Thomas M. Paradigms of lung microbiota functions in health and disease, particularly, in asthma. Front Physiol. 2018;9:1168.","journal-title":"Front Physiol"},{"issue":"19","key":"2132_CR51","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.3390\/ijms221910872","volume":"22","author":"K Yagi","year":"2021","unstructured":"Yagi K, Huffnagle G, Lukacs N, Asai N. The lung microbiome during health and disease. Int J Mol Sci. 2021;22(19):10872.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"2132_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaip.2015.05.030","volume":"3","author":"X Soler","year":"2015","unstructured":"Soler X, Ramsdell J. Are asthma and copd a continuum of the same disease? J Allergy Clin Immunol Pract. 2015;3(4):489\u201395.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"2132_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.763121","volume":"11","author":"M Metzger","year":"2021","unstructured":"Metzger M, Graeber S, Stahl M, Sommerburg O, Mall M, Dalpke A, Boutin S. A volatile and dynamic longitudinal microbiome is associated with less reduction in lung function in adolescents with cystic fibrosis. Front Cell Infect Microbiol. 2021;11: 763121.","journal-title":"Front Cell Infect Microbiol."},{"issue":"1","key":"2132_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","volume":"147","author":"A Dicker","year":"2021","unstructured":"Dicker A, Huang J, Lonergan M, Keir H, Fong C, Tan B, Cassidy A, Finch S, Mullerova H, Miller B, Tal-Singer R, Chalmers J. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147(1):158\u201367.","journal-title":"J Allergy Clin Immunol."},{"key":"2132_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/19490976.2016.1241933","volume":"7","author":"K Johnson","year":"2016","unstructured":"Johnson K, Burnet P. Microbiome: should we diversify from diversity? Gut Microbes. 2016;7:455\u20138.","journal-title":"Gut Microbes"},{"key":"2132_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49452-y","author":"L Wilkins","year":"2019","unstructured":"Wilkins L, Monga M, Miller A. Defining dysbiosis for a cluster of chronic diseases. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-49452-y.","journal-title":"Sci Rep"},{"key":"2132_CR57","doi-asserted-by":"crossref","unstructured":"Priya S, Blekhman R. Population dynamics of the human gut microbiome: change is the only constant. Genome Biol 2019. 10.1186\/s13059-019-1775-3","DOI":"10.1186\/s13059-019-1775-3"},{"issue":"2","key":"2132_CR58","doi-asserted-by":"publisher","first-page":"0264443","DOI":"10.1371\/journal.pone.0264443","volume":"17","author":"M Chiarello","year":"2022","unstructured":"Chiarello M, McCauley M, Villeger S, Jackson C. Ranking the biases: the choice of OTUS vs. ASVS in 16s rRNA amplicon data analysis has stronger effects on diversity measures than rarefaction and OTU identity threshold. PLoS ONE. 2022;17(2):0264443.","journal-title":"PLoS ONE"},{"issue":"12","key":"2132_CR59","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","volume":"2","author":"G Rogers","year":"2014","unstructured":"Rogers G, Bruce K, Martin M, Burr L, Serisier D. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir Med. 2014;2(12):988\u201396.","journal-title":"Lancet Respir Med."},{"key":"2132_CR60","doi-asserted-by":"crossref","unstructured":"Mac Aog\u00a0\u00e1in M, Chandrasekaran R, Lim A, Low T, Tan G, Hassan T, Ong T, Hui Qi\u00a0Ng A, Bertrand D, Koh J, Pang S, Lee Z, Gwee X, Martinus C, Sio Y, Matta S, Chew F, Keir H, Connolly J, Abisheganaden J, Koh M, Nagarajan N, Chalmers J, Chotirmall S. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018; 52(1), 1800766","DOI":"10.1183\/13993003.00766-2018"},{"key":"2132_CR61","doi-asserted-by":"crossref","unstructured":"Mac Aog\u00a0\u00e1in M, Narayana J, Tiew P, Ali N, Yong V, Jaggi T, Lim A, Keir H, Dicker A, Thng K, Tsang A, Ivan F, Poh M, Oriano M, Aliberti S, Blasi F, Low T, Ong T, Oliver B, Giam Y, Tee A, Koh M, Abisheganaden J, Tsaneva-Atanasova K, Chalmers J, Chotirmall S. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021; 27(4), 688\u2013699.","DOI":"10.1038\/s41591-021-01289-7"},{"key":"2132_CR62","doi-asserted-by":"crossref","unstructured":"Abdel-Aziz MI, Brinkman P, Vijverberg S, Neerincx A, Riley J, Bates S, Hashimoto S, Kermani N, Chung K, Djukanovic R, Dahl\u00e9n S, Adcock I, Howarth P, Sterk P, Kraneveld A, Maitland-van\u00a0der Zee, A, U-BIOPRED Study Group: Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months. J Allergy Clin Immunol. 2021; 147(1), 123\u2013134.","DOI":"10.1016\/j.jaci.2020.04.018"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02132-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T12:12:02Z","timestamp":1661256722000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02132-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02132-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}